Estimation of the Salivary Copper Levels in Oral Submucous Fibrosis Condition: An In Vivo Study
- PMID: 39364851
- DOI: 10.5005/jp-journals-10024-3661
Estimation of the Salivary Copper Levels in Oral Submucous Fibrosis Condition: An In Vivo Study
Abstract
Aim: The aim of the present study was to estimate the salivary copper levels in oral submucous fibrosis (OSMF) condition.
Materials and methods: A total of 60 individuals of which an equal number of 30 each in normal healthy control group as well as in clinically and histopathologically (the biopsy was done once after the clinical confirmation of OSMF in the patient) confirmed patients of OSMF were included in the study group. Total of 51 males and 9 females were considered for the present study and the age distribution of these groups ranged from a minimum of 21 years to a maximum of 74 years. Unstimulated whole saliva was collected from the patient followed by the conventional biopsy practice. The collected saliva was then subjected for the analysis of copper levels. Trace element copper was estimated by using Digital Semiautomatic Analyzer with the help of copper kit. The clinical mouth opening of OSMF was estimated. Analysis of variance (ANOVA) and Tukey HSD post hoc test was used analyze the data wherein the participants were grouped into age ranges of 20-30, 31-40, 41-50, and >60 years.
Results: The mean salivary copper level among OSMF and control groups with respect to age in 20-30 years was 55.98 ± 15.50 and 30.87 ± 7.70, in 31-40 years was 63.96 ± 21.13 and 32.95 ± 4.56, in 41-50 years was 50.11 ± 6.83 and 30.46 ± 3.28, and >60 years was 45.65 and 13.67 µg/dL, respectively. The mean salivary copper levels among OSMF and Control groups with respect to males were 55.60 ± 15.27 and 31.18 ± 6.97 and among females were 67.0 ± 24.25 and 30.06 ± 5.77 µg/dL, respectively. The mean salivary copper levels with histopathological grades in very early stage was 47.18 ± 5.73, in early stage was 49.22 ± 7.65, in moderately advanced was 73.53 ± 10.62 and in OSMF with mild dysplasia was 79.98 ± 16.27 µg/dL, respectively. The mean salivary copper levels in individuals with clinical mouth opening more than 35 mm was 45.65 ± 6.57, in 25-35 mm was 48.94 ± 21.60, in 15-25 mm was 70.54 ± 3.52 and in less than 15 mm was 81.50 ± 16.66, respectively.
Conclusion: The present study concluded that salivary trace element levels could be used as potential diagnostic and prognostic markers in patients with OSMF.
Clinical significance: Trace elements are involved in many different physiological and metabolic processes in humans, either directly or indirectly. Copper is involved in vital biochemical activities like different redox and free radical formation and in maintaining cellular proton homeostasis. It is also associated with the processing of oxygen and a component of arecanut in all forms, which is implicated in the etiology of OSMF. How to cite this article: Gupta R, Jayanti I, Das A, et al. Estimation of the Salivary Copper Levels in Oral Submucous Fibrosis Condition: An In Vivo Study. J Contemp Dent Pract 2024;25(5):498-502.
Keywords: Biopsy; Histopathology; Oral submucous fibrosis Salivary copper..
Similar articles
-
Effect of α-tocopherol on salivary reactive oxygen species and trace elements in oral submucous fibrosis.Ann Clin Biochem. 2012 May;49(Pt 3):262-5. doi: 10.1258/acb.2011.011050. Epub 2012 Feb 15. Ann Clin Biochem. 2012. PMID: 22337705
-
Estimation of Salivary and Serum Lactate Dehydrogenase in Oral Submucous Fibrosis.J Int Soc Prev Community Dent. 2018 Jul-Aug;8(4):289-295. doi: 10.4103/jispcd.JISPCD_214_18. Epub 2018 Jul 18. J Int Soc Prev Community Dent. 2018. PMID: 30123759 Free PMC article.
-
Estimation of copper in saliva and areca nut products and its correlation with histological grades of oral submucous fibrosis.J Oral Pathol Med. 2015 Mar;44(3):208-13. doi: 10.1111/jop.12222. Epub 2014 Jul 22. J Oral Pathol Med. 2015. PMID: 25047540
-
Alteration of salivary LPO, MDA, LDH, glutathione, GPx, SOD and vitamins in oral submucous fibrosis: A three-level meta-analysis study.Clin Biochem. 2024 Aug;130:110790. doi: 10.1016/j.clinbiochem.2024.110790. Epub 2024 Jul 3. Clin Biochem. 2024. PMID: 38969054
-
Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.Gulf J Oncolog. 2023 Jan;1(41):78-99. Gulf J Oncolog. 2023. PMID: 36804163
Cited by
-
Role of micronutrition in patients with oral cancer and nutritional intervention strategies.Front Nutr. 2025 Jul 24;12:1616344. doi: 10.3389/fnut.2025.1616344. eCollection 2025. Front Nutr. 2025. PMID: 40777177 Free PMC article. Review.